Tuberculosis screening before anti-hepatitis C virus therapy in prisons

Emerg Infect Dis. 2012 Apr;18(4):689-91. doi: 10.3201/eid1804.111016.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antiviral Agents / adverse effects*
  • Antiviral Agents / therapeutic use
  • Hepatitis C / diagnosis*
  • Hepatitis C / drug therapy
  • Humans
  • Interferon-alpha / adverse effects*
  • Interferon-alpha / therapeutic use
  • Male
  • Mass Screening
  • Polyethylene Glycols / adverse effects*
  • Polyethylene Glycols / therapeutic use
  • Prisoners
  • Radiography
  • Recombinant Proteins / adverse effects
  • Recombinant Proteins / therapeutic use
  • Recurrence
  • Ribavirin / adverse effects*
  • Ribavirin / therapeutic use
  • Tuberculosis, Pulmonary / diagnostic imaging*
  • Tuberculosis, Pulmonary / prevention & control*

Substances

  • Antiviral Agents
  • Interferon-alpha
  • Recombinant Proteins
  • Polyethylene Glycols
  • Ribavirin
  • peginterferon alfa-2a